Norways Crown Princess Mette-Marit placed on urgent lung transplant list
Norway’s Crown Princess Mette-Marit has been placed on the urgent national transplant list for a lung transplant, the Royal House announced Friday, as her chronic lung disease, pulmonary fibrosis, has taken a serious turn. Chief physician Are Holm confirmed the decision, stating that her condition now requires the procedure “as soon as possible.” The move follows a period of rapid health deterioration and comes as the Norwegian royal family adjusts public engagements and family schedules in response.
Mette-Marit, 52, was first diagnosed with pulmonary fibrosis in 2018, a progressive and incurable lung disease that causes scarring and stiffness in lung tissue, severely impairing breathing. Her condition has worsened in recent months, prompting the urgent listing at Oslo University Hospital, where she has been under specialist care. The hospital confirmed in a joint statement with the Royal House that a transplant could occur “at any time,” depending on donor availability and medical readiness.
The announcement has triggered a highly confidential process to identify a compatible donor, with Norwegian health authorities coordinating closely with international transplant networks. While the Royal House has not disclosed further clinical details, medical experts note that only patients with life-threatening conditions are placed on such urgent lists, typically when life expectancy without intervention is measured in weeks or months.
Family adjustments reflect the gravity of the situation. Mette-Marit’s daughter, Princess Ingrid Alexandra, returned from Australia this week, and the royal family has postponed official engagements. Her son, Marius Borg Høiby, has also requested temporary release from pre-trial detention, a move reported by Norwegian media as part of the family’s coordinated response to the health crisis.
Public reaction has been marked by widespread sympathy, with commentators emphasizing the human toll behind the royal title. Medical journalists have highlighted advances in lung transplant success rates, noting that while pulmonary fibrosis once carried a grim prognosis, modern care has improved outcomes significantly. DN’s medical reporter Anna Bratt wrote that today’s patients benefit from better post-transplant survival and quality of life than in previous decades.
The Royal House has scheduled a press briefing at Rikshospitalet in Oslo for later today, where further details may be provided. In the meantime, Norway’s medical and royal institutions are bracing for a delicate period of waiting—one that could end at any moment with life-changing surgery.
- dagens nyheter
- der standard
- independent
- aftenposten
- orf.at
- cphpost
- die presse
- svenska dagbladet
- faz







